[
  {
    "date": "2023-06-29",
    "symbol": "KTRA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KTRA",
    "security12btitle": "Common Stock",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "Kintara Therapeutics, Inc.",
    "entitycentralindexkey": 1498382,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityincorporationstatecountrycode": "NV",
    "entityfilenumber": "001-37823",
    "entitytaxidentificationnumber": "99-0360497",
    "entityaddressaddressline1": "9920 Pacific Heights Blvd",
    "entityaddressaddressline2": "Suite 150",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "350-4364",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Marcum LLP",
    "auditorfirmid": 688,
    "auditorlocation": "San Francisco, CA",
    "cashandcashequivalentsatcarryingvalue": 1535000,
    "prepaidexpensecurrent": 660000,
    "clinicaltrialdepositcurrent": 1075000,
    "assetscurrent": 3270000,
    "propertyplantandequipmentnet": 709000,
    "assets": 3979000,
    "accountspayableandaccruedliabilitiescurrent": 2784000,
    "duetorelatedpartiescurrent": 298000,
    "liabilitiescurrent": 3082000,
    "milestonepaymentliability": 166000,
    "liabilities": 3248000,
    "preferredstockvalue": 279000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 141438000,
    "retainedearningsaccumulateddeficit": -151375000,
    "accumulatedothercomprehensiveincomelossnetoftax": 21000,
    "stockholdersequity": 731000,
    "liabilitiesandstockholdersequity": 3979000,
    "preferredstocksharesauthorized": 5000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesissued": 279000,
    "preferredstocksharesoutstanding": 279000,
    "commonstocksharesauthorized": 75000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 1692000,
    "researchanddevelopmentexpense": 9311000,
    "generalandadministrativeexpense": 5485000,
    "operatingexpenses": 14796000,
    "foreigncurrencytransactiongainlossbeforetax": 10000,
    "otheroperatingincomeexpensenet": 137000,
    "nonoperatingincomeexpense": 147000,
    "netincomeloss": -14649000,
    "dividendspreferredstockcash": 8000,
    "preferredstockdividendsandotheradjustments": 362000,
    "netincomelossavailabletocommonstockholdersbasic": -15019000,
    "earningspersharebasic": -9.27,
    "weightedaveragenumberofsharesoutstandingbasic": 1620000,
    "sharesoutstanding": 1692000,
    "issuanceofsharesandwarrantsnetofissuecost": 1000,
    "issuanceofsharesandwarrantsnetofissuecostshare": 262000,
    "issuanceofsharesforservices": 110000,
    "issuanceofsharesforservicesamount": 16000,
    "conversionofseriescpreferredstocktocommonstock": 1909000,
    "conversionofseriescpreferredstocktocommonstockshare": 45000,
    "stockissuedduringperiodsharesreversestocksplits": 15000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1490000,
    "adjustmentstoadditionalpaidincapitalrestrictedstockunitexpense": 90000,
    "seriespreferredstockdividends": -8000,
    "seriesbpreferredstockdividend": 362000,
    "seriesbpreferredstockdividendshares": 43000,
    "profitloss": -14649000,
    "depreciation": 60000,
    "amortizationofintangibleassets": 3225000,
    "gainlossfromchangeinfairvalueofmilestoneliability": -3000,
    "increasedecreaseinrestrictedstockunitsandsharesissuedforservices": 200000,
    "stockoptionplanexpense": 1490000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -371000,
    "increasedecreaseinclinicaltrialdeposits": -1700000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -442000,
    "increasedecreaseinduetorelatedparties": -423000,
    "netcashprovidedbyusedinoperatingactivities": -11865000,
    "paymentstoacquiremachineryandequipment": 232000,
    "netcashprovidedbyusedininvestingactivities": -232000,
    "proceedsfromissuanceofsharesandwarrants": 1903000,
    "paymentsofstockissuancecosts": 43000,
    "paymentsofdividendspreferredstockandpreferencestock": 8000,
    "netcashprovidedbyusedinfinancingactivities": 1852000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -10245000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 1535000,
    "proceedsfromissuanceofcommonstock": 1903000,
    "descriptionofgrantfundingreceived": "In addition, on June 28, 2023, the Company announced that it had been awarded approximately $2.0 million in grant funding to be received over a two year period for its REM-001 project.",
    "stockholdersequityreversestocksplit": "As a result of the Reverse Stock Split, every 50 shares of issued and outstanding common stock were converted into one share of common stock with a proportionate reduction in the Company's authorized shares of common stock.",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentestimatedusefullives": "three to seven years",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 713000,
    "paymentstoacquirebusinessesgross": 300000,
    "businesscombinationcontingentconsiderationliability": 240000,
    "paymentstoemployees": 60000,
    "milestonepaymentliabilitychangeinfairvalueestimate": 3000,
    "patientenrollmentmilestonespayments": 5065000,
    "clinicaltrialdepositpayments": 1700000,
    "clinicaltrialdepositexpense": 3225000,
    "depositspayments": 1075000,
    "propertyequipmentandintangiblesassets": 709000,
    "propertyplantandequipmentadditions": 679000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipmentandintangiblesassets": 60000,
    "paymentsforsoftware": 859000,
    "capitalizedcostofpropertyandequipmentnotinuse": 679000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 159,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0267,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.914,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "temporaryequitycarryingamountincludingportionattributabletononcontrollinginterests": 10366000,
    "temporaryequitysharesoutstanding": 14208000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 2504000,
    "conversionofseriescpreferredstocktocommonstockshares": -2630000,
    "sharesissuedpricepershare": 1000,
    "commonstockdividendspercentage": 0.1,
    "debtinstrumentconvertibleconversionprice1": 58,
    "preferredstockliquidationpreferencevalue": 10366000,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2027-04-14",
    "classofwarrantorrightoutstanding": 11415000,
    "stockissuedduringperiodsharesissuedforservices": 16000,
    "stockissuedduringperiodvalueissuedforservices": 110000,
    "fullydilutedsharesofcommonstockpercentage": 0.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 70000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 34.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 812000,
    "unrecognizedcompensationexpenseterm": "P2Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P8Y9M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluenonvested": 90000,
    "classofwarrantorrightoutstandingnumberofconversion": 197000,
    "preferredstockdividendsshares": 153000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 275000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 160000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 198000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 56000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 51.71,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 102.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 6.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 6000,
    "allocatedsharebasedcompensationexpense": 451000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 118000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 44000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsunvestedweightedaverageexerciseprice": 24.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsgrantedweightedaverageexerciseprice": 8.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsvestedweightedaverageexerciseprice": 48.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 713000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 7000,
    "deferredtaxassetsoperatinglosscarryforwards": 29204000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 982000,
    "deferredtaxassetscapitallosscarryforwards": 18000,
    "deferredtaxassetsfinancingcost": 326000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebonuses": 37000,
    "deferredtaxassetsinprocessresearchanddevelopment": 895000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 769000,
    "deferredtaxassetsdeferredexpensecapitalizedresearchanddevelopmentcosts": 265000,
    "deferredtaxassetsliabilitiesnet": 32496000,
    "deferredtaxliabilitiesscientificresearchanddevelopment": 127000,
    "deferredtaxassetsgross": 32369000,
    "deferredtaxassetsvaluationallowance": 32369000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 34100000,
    "percentageoftaxableincomelimitationonnols": 0.8,
    "taxcreditcarryforwarddescription": "expire between 2031 and 2042",
    "opentaxyear": "2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022",
    "minimumcumulativepercentageofchangeinownershipasconditiontooffsettaxableincomeortax": 0.5,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 6700000,
    "operatinglosscarryforwards": 109300000,
    "operatinglosscarryforwardslimitationsonuse": "begin expiring in 2026",
    "investmenttaxcredit": 470000,
    "cumulativechangeinownershipperiod": "P3Y",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3076000,
    "incometaxreconciliationpermanentdifferences": -1095000,
    "incometaxreconciliationforeignincometaxratedifferential": -127000,
    "incometaxreconciliationeffectofforeignexchangerates": 66000,
    "incometaxreconciliationnondeductibleexpensebenefitresearchanddevelopment": -61000,
    "incometaxreconciliationadjustmenttoprioryearsprovisionversusstatutorytaxreturns": -106000,
    "incometaxreconciliationotheradjustments": 13000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 4386000,
    "remainingcommitmentsrelatedtodrugmanufacturingandclinicalstudymanagementandsafety": 3200000,
    "clinicaldevelopmentresearchdeposits": 4300000,
    "periodicleaserentterm": "P1Y",
    "periodicleaserentpayment": 2400,
    "operatingleaseexpense": 39000,
    "noncashissuecosts": 289000,
    "equipmentadditionsreclassifiedfromprepaidexpenses": 447000,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 22000,
    "descriptionofforeigncurrencyexposure": "Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If foreign exchange rates were to fluctuate within +/-10% of the closing rate at year-end, the maximum exposure is $7.",
    "foreignexchangeriskmaximumexposure": 7000,
    "descriptionofinterestrateriskexposure": "The Company’s cash balance currently earns interest at standard bank rates. If interest rates were to fluctuate within +/-10% of the closing rate at year end the impact of the Company’s interest-bearing accounts will not be significant due to the current low market interest rates.",
    "liquidityriskmaximumexposure": 3248000,
    "concentrationriskcreditriskfinancialinstrumentmaximumexposure": 12000,
    "concentrationriskcreditriskuninsuredamountofcash": 957000,
    "accountspayabletradecurrentandnoncurrent": 51000,
    "cash": 13000,
    "interestreceivableandotherassets": 8000,
    "cashfdicinsuredamount": 578000,
    "cashuninsuredamount": 957000
  },
  {
    "date": "2022-06-29",
    "symbol": "KTRA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "June 30, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KTRA",
    "security12btitle": "Common Stock",
    "securityexchangename": "Nasdaq",
    "entityregistrantname": "Kintara Therapeutics, Inc.",
    "entitycentralindexkey": 1498382,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityincorporationstatecountrycode": "Nevada",
    "entityfilenumber": "001-37823",
    "entitytaxidentificationnumber": "99-0360497",
    "entityaddressaddressline1": "9920 Pacific Heights Blvd",
    "entityaddressaddressline2": "Suite 150",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "350-4364",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Marcum LLP",
    "auditorfirmid": 688,
    "auditorlocation": "San Francisco, CA",
    "cashandcashequivalentsatcarryingvalue": 11780000,
    "prepaidexpensecurrent": 1478000,
    "assetscurrent": 13258000,
    "clinicaltrialdepositnoncurrent": 2600000,
    "propertyplantandequipmentnet": 90000,
    "assets": 15948000,
    "accountspayableandaccruedliabilitiescurrent": 3269000,
    "duetorelatedpartiescurrent": 721000,
    "liabilitiescurrent": 3990000,
    "milestonepaymentliability": 163000,
    "liabilities": 4153000,
    "preferredstockvalue": 12275000,
    "commonstockvalue": 66000,
    "additionalpaidincapitalcommonstock": 135510000,
    "retainedearningsaccumulateddeficit": -136356000,
    "accumulatedothercomprehensiveincomelossnetoftax": 21000,
    "stockholdersequity": -136356000,
    "liabilitiesandstockholdersequity": 15948000,
    "preferredstocksharesauthorized": 5000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesissued": 17000,
    "preferredstocksharesoutstanding": 17000,
    "commonstocksharesauthorized": 275000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 22000000,
    "researchanddevelopmentexpense": 15173000,
    "generalandadministrativeexpense": 7509000,
    "operatingexpenses": 22682000,
    "foreigncurrencytransactiongainlossbeforetax": 7000,
    "otheroperatingincomeexpensenet": 14000,
    "nonoperatingincomeexpense": 21000,
    "netincomeloss": -22661000,
    "dividendspreferredstockcash": 8000,
    "preferredstockdividendsandotheradjustments": 2462000,
    "netincomelossavailabletocommonstockholdersbasic": -25131000,
    "earningspersharebasic": -0.52,
    "weightedaveragenumberofsharesoutstandingbasic": 48702000,
    "sharesoutstanding": 65533000,
    "issuanceofsharesandwarrantsnetofissuecost": 21526000,
    "issuanceofsharesandwarrantsnetofissuecostshare": 23427000,
    "conversionofseriescpreferredstocktocommonstock": 2377000,
    "conversionofseriescpreferredstocktocommonstockshare": 2799000,
    "adjustmentofwarrantsgrantedforservices": 35000,
    "exerciseof2020investorwarrantsforcash": 69000,
    "exerciseof2020investorwarrantsforcashshares": 69000,
    "exerciseofprefundedwarrantsforcash": 5000,
    "exerciseofprefundedwarrantsforcashshares": 4800000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2248000,
    "seriespreferredstockdividends": -8000,
    "seriescpreferredstockdividend": -2462000,
    "seriescpreferredstockdividendshares": 1698000,
    "profitloss": -22661000,
    "depreciation": 60000,
    "gainlossfromchangeinfairvalueofmilestoneliability": 19000,
    "increasedecreaseinfairvalueofwarrantsissuedforservices": 35000,
    "stockoptionplanexpense": 2248000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 722000,
    "increasedecreaseinclinicaltrialdeposits": -500000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1007000,
    "increasedecreaseinduetorelatedparties": 160000,
    "netcashprovidedbyusedinoperatingactivities": -20392000,
    "proceedsfromissuanceofsharesandwarrants": 21569000,
    "proceedsfromwarrantexercises": 4800,
    "paymentsofdividendspreferredstockandpreferencestock": 8000,
    "netcashprovidedbyusedinfinancingactivities": 21635000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 1243000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 11780000,
    "commonstockconversionbasis": 1.574,
    "numberofregistereddirectfinancingscompleted": 2,
    "proceedsfromregistereddirectfinancingsubsequent": 21600000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentestimatedusefullives": " three years",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 14497000,
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissued": 11439,
    "businessacquisitionstockpurchasewarrants": 2314,
    "businessacquisitionclassofwarrantexercisableprice": 3.18,
    "weightedaverageriskfreeinterestrate": 0.0021,
    "volatilityrate": 1.1596,
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissuedasmergerfee": 572,
    "weightedaverageremainingterm": "one year",
    "commonstockdividendspercentage": 0.25,
    "businessacquisitionshareprice": 1.34,
    "legalfees": 1554000,
    "professionalfees": 500000,
    "paymentstoacquirebusinessesgross": 700000,
    "businesscombinationcontingentconsiderationliability": 560000,
    "paymentstoemployees": 140000,
    "businesscombinationconsiderationtransferred1": 16724000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 969000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsother": 11000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedpropertyplantandequipment": 175000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesaccountspayable": 337000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesother": 188000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesinprocessresearchanddevelopment": 16094000,
    "milestonepaymentliabilitychangeinfairvalueestimate": -19000,
    "patientenrollmentmilestonespayments": 8163000,
    "depositspayments": 2600000,
    "propertyequipmentandintangiblesassets": 90000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipmentandintangiblesassets": 60000,
    "paymentsforsoftware": 80000,
    "preferredstockdividendratepercentage": 0.09,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.021800000000000003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9400000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.1,
    "temporaryequitycarryingamountincludingportionattributabletononcontrollinginterests": 12275000,
    "temporaryequitysharesoutstanding": 16838,
    "temporaryequitystockissuedduringperiodsharesnewissues": 2504,
    "conversionofseriescpreferredstocktocommonstockshares": -3254,
    "sharesissuedpricepershare": 1000,
    "proceedsfromissuanceofconvertiblepreferredstock": 25028000,
    "netproceedsfromprivateplacement": 21598000,
    "paymentsofstockissuancecosts": 3455000,
    "stockissuedduringperiodsharesnewissues": 2504,
    "preferredstockfairvalue": 3287000,
    "debtinstrumentconvertibleconversionprice1": 1.15,
    "preferredstockliquidationpreferencevalue": 279000,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "September 20, 2022",
    "classofwarrantorrightoutstanding": 296000,
    "commonstocksharesoutstanding": 117000,
    "commonstockissuedunder2017plan": 8693000,
    "fullydilutedsharesofcommonstockpercentage": 0.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3964,
    "allocatedsharebasedcompensationexpense": 2248000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4611000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 0.96,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1237000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8810000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 1792000,
    "unrecognizedcompensationexpenseterm": 2.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": 9.19,
    "equityfairvaluedisclosure": 3287000,
    "warrantsandrightsoutstandingmeasurementinput": 95.8,
    "warrantsandrightsoutstandingterm": 4,
    "classofwarrantorrightoutstandingnumberofconversion": 2100000,
    "preferredstockdividendsshares": 3625000,
    "conversionofpreferredstockseriesbtocommonstock": -4525000,
    "conversionofpreferredstockseriesbtocommonstockshares": -649000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 309000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.68,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 8.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 2388,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 1237,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsunvestedweightedaverageexerciseprice": 4199,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsgrantedweightedaverageexerciseprice": 0.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsvestedweightedaverageexerciseprice": 1.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsforfeitedweightedaverageexerciseprice": 1.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 36024000,
    "numberofsharesexerciseofprefundedwarrants": -4800000,
    "numberofwarrantsexerciseofinvestorwarrants": 69000,
    "issuanceof2022investorwarrants": 12000000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuanceofinvestorwarrantsweightedaverageexerciseprice": 1.25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuance2022agentwarrantsweightedaverageexerciseprice": 1.5625,
    "issuanceof2022aprilinvestorwarrants": 16226000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuanceofaprilinvestorwarrantsweightedaverageexerciseprice": 0.41,
    "issuanceof2022aprilagentwarrants": 1623000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuanceof2022aprilagentwarrantsweightedaverageexerciseprice": 0.6625,
    "issuanceofpfw": 4800000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuancepwfweightedaverageexerciseprice": 0.001,
    "issuanceof2022agentwarrants": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 1330000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexerciseofprefundedwarrantsweightedaverageexerciseprice": 0.001,
    "commonstockdividendsshares": 1470000,
    "deferredtaxassetsoperatinglosscarryforwards": 25541000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 635000,
    "deferredtaxassetscapitallosscarryforwards": 18000,
    "deferredtaxassetsfinancingcost": 326000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebonuses": 85000,
    "deferredtaxassetsinprocessresearchanddevelopment": 803000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 690000,
    "deferredtaxassetsliabilitiesnet": 28098000,
    "deferredtaxliabilitiesscientificresearchanddevelopment": 114000,
    "deferredtaxassetsgross": 27984000,
    "deferredtaxassetsvaluationallowance": 27984000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 29700000,
    "percentageoftaxableincomelimitationonnols": 0.8,
    "taxcreditcarryforwarddescription": "expire between 2022 and 2031",
    "opentaxyear": "2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021",
    "minimumcumulativepercentageofchangeinownershipasconditiontooffsettaxableincomeortax": 0.5,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 4300000,
    "operatinglosscarryforwards": 50800000,
    "operatinglosscarryforwardslimitationsonuse": " begin expiring in 2030",
    "investmenttaxcredit": 3000000,
    "cumulativechangeinownershipperiod": "three-year",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -4743000,
    "incometaxreconciliationpermanentdifferences": 802000,
    "incometaxreconciliationforeignincometaxratedifferential": -345000,
    "incometaxreconciliationeffectofforeignexchangerates": 445000,
    "incometaxreconciliationnondeductibleexpensebenefitresearchanddevelopment": -44000,
    "incometaxreconciliationadjustmenttoprioryearsprovisionversusstatutorytaxreturns": -2332000,
    "incometaxreconciliationotheradjustments": 196000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 6021000,
    "manufacturingandclinicalstudymanagementrelatedcost": 14880000,
    "clinicaldevelopmentresearchdeposits": 3269000,
    "periodicleaserentterm": "one-year",
    "periodicleaserentpayment": 4400,
    "operatingleaseexpense": 41400,
    "noncashissuecosts": 683000,
    "issuecostsinaccountspayable": 43000,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 57000,
    "descriptionofforeigncurrencyexposure": "Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If foreign exchange rates were to fluctuate within +/-10% of the closing rate at year-end, the maximum exposure is $14.",
    "foreignexchangeriskmaximumexposure": 14000,
    "descriptionofinterestrateriskexposure": "The Company’s cash balance currently earns interest at standard bank rates. If interest rates were to fluctuate within +/-10% of the closing rate at year end the impact of the Company’s interest-bearing accounts will not be significant due to the current low market interest rates.",
    "liquidityriskmaximumexposure": 4282000,
    "concentrationriskcreditriskfinancialinstrumentmaximumexposure": 19000,
    "concentrationriskcreditriskuninsuredamountofcash": 11185000,
    "accountspayabletradecurrentandnoncurrent": 74000,
    "cash": 27000,
    "interestreceivableandotherassets": 11000,
    "cashfdicinsuredamount": 595000,
    "cashuninsuredamount": 11185000,
    "stockoptioncommencingdatedescription": "The restricted stock units vest in four equal amounts commencing August 1, 2023."
  },
  {
    "date": "2021-06-29",
    "symbol": "KTRA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "June 30, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KTRA",
    "security12btitle": "Common Stock",
    "securityexchangename": "Nasdaq",
    "entityregistrantname": "Kintara Therapeutics, Inc.",
    "entitycentralindexkey": 1498382,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityincorporationstatecountrycode": "Nevada",
    "entityfilenumber": "001-37823",
    "entitytaxidentificationnumber": "99-0360497",
    "entityaddressaddressline1": "12707 High Bluff Dr",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "350-4364",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 10537000,
    "prepaidexpensecurrent": 756000,
    "clinicaltrialdepositcurrent": 500000,
    "assetscurrent": 11793000,
    "clinicaltrialdepositnoncurrent": 1600000,
    "propertyplantandequipmentnet": 150000,
    "assets": 13543000,
    "accountspayableandaccruedliabilitiescurrent": 2219000,
    "duetorelatedpartiescurrent": 561000,
    "liabilitiescurrent": 2780000,
    "milestonepaymentliability": 182000,
    "liabilities": 2962000,
    "preferredstockvalue": 14652000,
    "commonstockvalue": 33000,
    "additionalpaidincapitalcommonstock": 106821000,
    "retainedearningsaccumulateddeficit": -111225000,
    "accumulatedothercomprehensiveincomelossnetoftax": 21000,
    "stockholdersequity": -111225000,
    "liabilitiesandstockholdersequity": 13543000,
    "preferredstocksharesauthorized": 5000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesissued": 20000,
    "preferredstocksharesoutstanding": 20000,
    "commonstocksharesauthorized": 175000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 13000,
    "researchanddevelopmentexpense": 11815000,
    "generalandadministrativeexpense": 9757000,
    "mergercosts": 500000,
    "inprogressresearchanddevelopmentexpense": 16094000,
    "operatingexpenses": -38166000,
    "foreigncurrencytransactiongainlossbeforetax": -12000,
    "otheramortizationofdeferredcharges": 94000,
    "otheroperatingincomeexpensenet": -26000,
    "nonoperatingincomeexpense": -132000,
    "netincomeloss": -38298000,
    "dividendspreferredstockstock": 3181000,
    "dividendspreferredstockcash": 8000,
    "preferredstockdividendsandotheradjustments": 17000,
    "netincomelossavailabletocommonstockholdersbasic": -41504000,
    "earningspersharebasic": -1.6,
    "weightedaveragenumberofsharesoutstandingbasic": 25886000,
    "sharesoutstanding": 32740000,
    "adgeromergervalue": 16725000,
    "adgeromergershares": 12011000,
    "issuanceofseriescpreferredstock": 25028000,
    "seriescplacementagentwarrants": -3287000,
    "seriescpreferredstockissuecosts": -3455000,
    "dividendsrecognizedonbeneficialconversionofpreferredstockpriceincreasedecrease": -3181000,
    "exerciseofwarrantsforcash": 4404000,
    "exerciseofwarrantsforcashshares": 503000,
    "conversionofseriesbpreferredstocktocommonstock": -4525000,
    "conversionofseriesbpreferredstocktocommonstockshares": 12,
    "conversionofseriescpreferredstocktocommonstock": 3713000,
    "conversionofseriescpreferredstocktocommonstockshare": 4251000,
    "seriescagentwarrantsexercised": 79000,
    "adjustmentofwarrantsgrantedforservices": 569000,
    "stockissuedduringperiodvaluestockoptionsexercised": 77000,
    "stockissuedduringperiodsharesstockoptionsexercised": 195000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5276000,
    "seriespreferredstockdividends": -8000,
    "seriesbpreferredstockdividend": -17000,
    "seriesbpreferredstockdividendshares": 11,
    "profitloss": -38298000,
    "amortizationofintangibleassets": 2000,
    "depreciation": 30000,
    "gainlossfromchangeinfairvalueofmilestoneliability": 6000,
    "interestexpense": 30000,
    "amortizationofdeferredloancosts": 94000,
    "increasedecreaseinfairvalueofwarrantsissuedforservices": 569000,
    "stockoptionplanexpense": 5276000,
    "increasedecreaseinprepaidexpensesother": 381000,
    "increasedecreaseinclinicaltrialdeposits": -2100000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -67000,
    "increasedecreaseinduetorelatedparties": -103000,
    "netcashprovidedbyusedinoperatingactivities": -18860000,
    "cashacquiredfromacquisition": 969000,
    "paymentstoacquiremachineryandequipment": 8000,
    "proceedsfromsaleofmachineryandequipment": 3000,
    "netcashprovidedbyusedininvestingactivities": 964000,
    "proceedsfromissuanceofsharesandwarrants": 21598000,
    "proceedsfromwarrantexercises": 94000,
    "proceedsfromstockoptionsexercised": 77000,
    "proceedsfromconstructionloanspayable": 500000,
    "repaymentsofdebt": 500000,
    "interestpaid": 30000,
    "paymentsoffinancingcosts": 94000,
    "paymentsofdividendspreferredstockandpreferencestock": 8000,
    "netcashprovidedbyusedinfinancingactivities": 26041000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 8145000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 10537000,
    "proceedsfromregistereddirectfinancingsubsequent": 13600000,
    "substantialdoubtaboutcompanysabilitytocontinuesgoingconcernperiod": "one year",
    "finitelivedintangibleassetusefullife": "three years",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentestimatedusefullives": "three years",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 17295000,
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissued": 11439,
    "businessacquisitionstockpurchasewarrants": 2314,
    "businessacquisitionclassofwarrantexercisableprice": 3.18,
    "businessacquisitionequityinterestsissuedorissuablenumberofsharesissuedasmergerfee": 572,
    "weightedaverageriskfreeinterestrate": 0.0021,
    "weightedaverageremainingterm": "one year",
    "volatilityrate": 1.1596,
    "commonstockdividendspercentage": 0.25,
    "businessacquisitionshareprice": 1.34,
    "legalfees": 500000,
    "paymentstoacquirebusinessesgross": 700000,
    "businesscombinationcontingentconsiderationliability": 560000,
    "paymentstoemployees": 140000,
    "businesscombinationconsiderationtransferred1": 16724000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 969000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsother": 11000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedpropertyplantandequipment": 175000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesaccountspayable": 337000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesother": 188000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesinprocessresearchanddevelopment": 16094000,
    "milestonepaymentliabilityaddition": 188000,
    "milestonepaymentliabilitychangeinfairvalueestimate": -6000,
    "patientenrollmentmilestonespayments": 5430000,
    "depositspayments": 2600000,
    "depositpaymentexpensed": 500000,
    "remainderofdepositspaymentsanticipatedtofutureinvoice": 2100000,
    "depositspaymentsanticipatedshortterm": 500000,
    "depositspaymentsanticipatedlongterm": 1600000,
    "propertyequipmentandintangiblesassets": 150000,
    "propertyequipmentandintangiblesassetsgross": 182000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipmentandintangiblesassets": 32000,
    "paymentsforsoftware": 80000,
    "adjustmentforamortization": 2000,
    "funding": 500000,
    "paymentofprincipalandinterest": 530000,
    "proceedsfromissuanceoflongtermdebt": 500000,
    "warrantsissued": 125,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1.15,
    "debtinstrumentinterestratestatedpercentage": 0.06,
    "debtinstrumentmaturitydate": "June 19, 2021",
    "repaymentofloan": 500000,
    "repaymentofloaninterest": 30000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0037,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8982,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "temporaryequitycarryingamountincludingportionattributabletononcontrollinginterests": 14652000,
    "temporaryequitysharesoutstanding": 20092,
    "temporaryequitystockissuedduringperiodvaluenewissues": 18286000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 2504,
    "issuedonexerciseofseriescpreferredagentwarrants": 79000,
    "issuedonexerciseofseriescpreferredagentwarrantsshares": 33,
    "conversionofseriescpreferredstocktocommonstockshares": -4969,
    "sharesissuedpricepershare": 1000,
    "proceedsfromissuanceofconvertiblepreferredstock": 25028000,
    "netproceedsfromprivateplacement": 21573000,
    "paymentsofstockissuancecosts": 3455000,
    "stockissuedduringperiodsharesnewissues": 2504,
    "preferredstockfairvalue": 3287000,
    "debtinstrumentconvertibleconversionprice1": 1.15,
    "conversionofstocksharesissued1": 21516,
    "cumulativedividends": 15062000,
    "convertiblepreferredstocksharesissueduponconversion": 48,
    "preferredstockliquidationpreferencevalue": 279000,
    "increasedecreaseretainedearningsdeficit": 17000,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "January 17, 2022",
    "classofwarrantorrightoutstanding": 296,
    "commonstocksharesoutstanding": 136,
    "commonstockissuedunder2017plan": 6256,
    "fullydilutedsharesofcommonstockpercentage": 0.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 5074,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardexerciseperiod": "one year",
    "allocatedsharebasedcompensationexpense": 5276000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2532000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardacceleratedvestingnumber": 280000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardacceleratedcompensationcost": 53000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 16.14,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 14000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4279000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4759,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2181,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3014000,
    "unrecognizedcompensationexpenseterm": 2.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedintrinsicvalue": 2577,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P9Y1M28D",
    "equityfairvaluedisclosure": 3287000,
    "warrantsandrightsoutstandingmeasurementinput": 95.8,
    "warrantsandrightsoutstandingterm": 4,
    "classofwarrantorrightoutstandingnumberofconversion": 2100000,
    "preferredstockdividendsshares": 4324000,
    "conversionofpreferredstockseriesbtocommonstock": -4525000,
    "conversionofpreferredstockseriesbtocommonstockshares": -649000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 32000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.34,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 3860,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 2058,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsunvestedweightedaverageexerciseprice": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsgrantedweightedaverageexerciseprice": 1.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsvestedweightedaverageexerciseprice": 1.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsforfeitedweightedaverageexerciseprice": 1.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 6974000,
    "issuanceofadgerowarrants": 2314000,
    "warrantsissuedforservicesshare": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 4907000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 1342000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuanceofadgerowarrantsweightedaverageexerciseprice": 3.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionswarrantsissuedforservicesweightedaverageexerciseprice": 1.74,
    "numberofwarrantsexerciseofinvestorwarrantsforcash": 4404000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 273000,
    "numberofwarrantsissued": 2504,
    "classofwarrantorrightnumberofwarrantsorrightsexercised": -60,
    "commonstockdividendsshares": 1470000,
    "deferredtaxassetsoperatinglosscarryforwards": 20148000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 155000,
    "deferredtaxassetscapitallosscarryforwards": 18000,
    "deferredtaxassetsfinancingcost": 326000,
    "deferredtaxassetsinprocessresearchanddevelopment": 761000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 665000,
    "deferredtaxassetsliabilitiesnet": 22073000,
    "deferredtaxliabilitiesscientificresearchanddevelopment": 110000,
    "deferredtaxassetsgross": 21963000,
    "deferredtaxassetsvaluationallowance": 21963000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 9200000,
    "operatinglosscarryforwards": 41500000,
    "operatinglosscarryforwardslimitationsonuse": "begin expiring in 2030",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 20400000,
    "percentageoftaxableincomelimitationonnols": 0.8,
    "investmenttaxcredit": 2800000,
    "taxcreditcarryforwarddescription": "expire between 2021 and 2030",
    "opentaxyear": "2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021",
    "minimumcumulativepercentageofchangeinownershipasconditiontooffsettaxableincomeortax": 0.5,
    "cumulativechangeinownershipperiod": "P3Y",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -8015000,
    "incometaxreconciliationpermanentdifferences": 4506000,
    "incometaxreconciliationforeignincometaxratedifferential": -551000,
    "incometaxreconciliationeffectofforeignexchangerates": -954000,
    "incometaxreconciliationnoncapitallossesacquired": -4114000,
    "incometaxreconciliationnondeductibleexpensebenefitresearchanddevelopment": 97000,
    "incometaxreconciliationadjustmenttoprioryearsprovisionversusstatutorytaxreturns": 228000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8803000,
    "manufacturingandclinicalstudymanagementrelatedcost": 10049000,
    "clinicaldevelopmentresearchdeposits": 2310000,
    "periodicleaserentterm": "P1Y",
    "periodicleaserentpayment": 4400,
    "leaseandrentalexpense": 40000,
    "noncashissuecosts": 3287000,
    "cashlessexerciseofwarrants": 79000,
    "conversionofseriesbpreferredstocksharestocommonstock": 4525000,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 59000,
    "descriptionofforeigncurrencyexposure": "Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If foreign exchange rates were to fluctuate within +/-10% of the closing rate at year-end, the maximum exposure is $10.",
    "foreignexchangeriskmaximumexposure": 10000,
    "descriptionofinterestrateriskexposure": "The Company’s cash balance currently earns interest at standard bank rates. If interest rates were to fluctuate within +/-10% of the closing rate at year end the impact of the Company’s interest-bearing accounts will be not be significant due to the current low market interest rates.",
    "liquidityriskmaximumexposure": 2962000,
    "concentrationriskcreditriskfinancialinstrumentmaximumexposure": 8000,
    "concentrationriskcreditriskuninsuredamountofcash": 9909000,
    "accountspayabletradecurrentandnoncurrent": 114000,
    "cash": 30000,
    "interestreceivableandotherassets": 11000,
    "cashfdicinsuredamount": 628000,
    "cashuninsuredamount": 9909000
  },
  {
    "date": "2020-06-29",
    "symbol": "KTRA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-06-30",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KTRA",
    "security12btitle": "Common Stock",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "Kintara Therapeutics, Inc.",
    "entitycentralindexkey": 1498382,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityincorporationstatecountrycode": "NV",
    "entityfilenumber": "001-37823",
    "entitytaxidentificationnumber": "99-0360497",
    "entityaddressaddressline1": "12707 High Bluff Dr",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "350-4364",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 2392402,
    "prepaidexpensecurrent": 355580,
    "taxesandotherreceivablescurrent": 9401,
    "deferredcostscurrent": 93701,
    "assetscurrent": 2851084,
    "finitelivedintangibleassetsnet": 2109,
    "deferredcosts": 84944,
    "assets": 2938137,
    "accountspayableandaccruedliabilitiescurrent": 2011058,
    "duetorelatedpartiescurrent": 663865,
    "liabilities": 2674923,
    "preferredstockvalue": 4524897,
    "commonstockvalue": 11458,
    "additionalpaidincapitalcommonstock": 56624048,
    "warrantsandrightsoutstanding": 8524336,
    "retainedearningsaccumulateddeficit": -69721233,
    "accumulatedothercomprehensiveincomelossnetoftax": 21178,
    "stockholdersequity": 4524897,
    "liabilitiesandstockholdersequity": 2938137,
    "preferredstocksharesauthorized": 5000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesissued": 648613,
    "preferredstocksharesoutstanding": 648613,
    "commonstocksharesauthorized": 95000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 11457928,
    "researchanddevelopmentexpense": 3630024,
    "generalandadministrativeexpense": 4514520,
    "mergercosts": 1053697,
    "operatingexpenses": 9198241,
    "foreigncurrencytransactiongainlossbeforetax": -2923,
    "otheroperatingincomeexpensenet": 75248,
    "nonoperatingincomeexpense": 72325,
    "netincomeloss": -9125916,
    "preferredstockdividendsandotheradjustments": 8616,
    "netincomelossavailabletocommonstockholdersbasic": -9134532,
    "earningspersharebasic": 0.87,
    "weightedaveragenumberofsharesoutstandingbasic": 10444045,
    "sharesoutstanding": 648613,
    "issuanceofsharesandwarrantsnetofissuecost": 6582966,
    "issuanceofsharesandwarrantsnetofissuecostshare": 4895000,
    "exerciseofprefundedwarrantsforcash": 26550,
    "exerciseofprefundedwarrantsforcashshares": 2655000,
    "exerciseofwarrantsforcash": 25000,
    "exerciseofwarrantsforcashshares": 25000,
    "conversionofseriesbpreferredstocktocommonstock": -174407,
    "conversionofseriesbpreferredstocktocommonstockshares": 162177,
    "stockissuedduringperiodvalueissuedforservices": 13396,
    "stockissuedduringperiodsharesissuedforservices": 22520,
    "adjustmentofwarrantsgrantedforservices": 287183,
    "warrantsexpired": -29877,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 494861,
    "seriespreferredstockdividends": -8356,
    "seriesbpreferredstockdividend": -8616,
    "seriesbpreferredstockdividendshares": 14800,
    "profitloss": -9125916,
    "amortizationofintangibleassets": 9953,
    "issuanceofstockforservices": 13396,
    "increasedecreaseinfairvalueofwarrantsissuedforservices": 193482,
    "stockoptionplanexpense": 494861,
    "increasedecreaseinprepaidexpense": 75332,
    "increasedecreaseintaxesandotherreceivables": -16786,
    "increasedecreaseinaccountspayableandaccruedliabilities": 206597,
    "increasedecreaseinduetorelatedparties": 338657,
    "netcashprovidedbyusedinoperatingactivities": -7927516,
    "proceedsfromissuanceofsharesandwarrants": 6582966,
    "proceedsfromwarrantexercises": 720165,
    "paymentsofdividendspreferredstockandpreferencestock": 8356,
    "deferredfinancingcosts": -25000,
    "netcashprovidedbyusedinfinancingactivities": 6601160,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1326356,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2392402,
    "proceedsfromissuanceofprivateplacement": 25000000,
    "netproceedsfromprivateplacement": 21700000,
    "finitelivedintangibleassetusefullife": "P3Y",
    "paymentsforsoftware": 79910,
    "adjustmentforamortization": 9953,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 162177,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "derivativeliabilities": 29594,
    "deferredcostscurrentandnoncurrent": 178645,
    "deferredfinancecostsnet": 84944,
    "deferredloancosts": 93701,
    "classofwarrantorrightissued": 125000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.015,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.02,
    "classofwarrantorrightexercised": 2180,
    "warrantsexpirationdate": "2020-07-15",
    "issuanceofagentwarrants": 2180,
    "agentwarrantsissuedtopurchaseofcommonstock": 2180,
    "conversionofpreferredstockseriesbtocommonstockshares": -25000,
    "conversionofpreferredstockseriesbtocommonstock": -174407,
    "convertiblepreferredstocksharesissueduponconversion": 25000,
    "preferredstockliquidationpreferencevalue": 278530,
    "increasedecreaseretainedearningsdeficit": 8616,
    "classofwarrantorrightoutstanding": 10309456,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2021-02-01",
    "commonstockissuedunder2017plan": 491817,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1291016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 499748,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 701691,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1559199,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 79554,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 34847,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 177442,
    "unrecognizedcompensationexpenseterm": "P1Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedintrinsicvalue": 44754,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P9Y2M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionscancelledinperiod": 120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 18750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 1250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.61,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 0.61,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 40,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y11M1D",
    "allocatedsharebasedcompensationexpense": 494861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 857508,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 18750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsunvestedweightedaverageexerciseprice": 0.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsgrantedweightedaverageexerciseprice": 0.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsvestedweightedaverageexerciseprice": 1.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsforfeitedweightedaverageexerciseprice": 0.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 0.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 1.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 0.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 10309456,
    "warrantsissuedforservicesshare": 655000,
    "numberofwarrantsissuedtoinvestor": 10417500,
    "numberofunderwriterwarrants": 377500,
    "numberofsharesexerciseofprefundedwarrants": -2655000,
    "numberofwarrantsexerciseofinvestorwarrants": 25000,
    "expiryofwarrantsforservices": -4140,
    "stockissuedduringperiodwarrantsissuedforservices": 287183,
    "underwrittenpublicofferingvalue": 3924384,
    "issuanceofunderwriterwarrants": 164436,
    "numberofsharesexerciseofprefundedwarrantsvalue": -2397935,
    "stockissuedduringperiodvaluecashlessexerciseofwarrantsone": -12138,
    "expiryofwarrantsissuedforservicesvalue": -29877,
    "numberofwarrantsexerciseofinvestorwarrantsforcash": 197500,
    "proceedsfromwarrantexercisesgross": 790000,
    "paymentofwarrantexpenses": 69835,
    "deferredtaxassetsoperatinglosscarryforwards": 11870922,
    "deferredtaxassetscapitallosscarryforwards": 17925,
    "deferredtaxassetsfinancingcost": 221276,
    "deferredtaxassetsinprocessresearchanddevelopment": 604489,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 534355,
    "deferredtaxassetsliabilitiesnet": 13248967,
    "deferredtaxliabilitiesscientificresearchanddevelopment": 88929,
    "deferredtaxassetsgross": 13160038,
    "deferredtaxassetsvaluationallowance": 13160038,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 4000000,
    "operatinglosscarryforwards": 30600000,
    "operatinglosscarryforwardslimitationsonuse": "begin expiring in 2030",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 6700000,
    "percentageoftaxableincomelimitationonnols": 0.8,
    "investmenttaxcredit": 2200000,
    "taxcreditcarryforwarddescription": "expire between 2020 and 2030",
    "opentaxyear": "2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020",
    "minimumcumulativepercentageofchangeinownershipasconditiontooffsettaxableincomeortax": 0.5,
    "cumulativechangeinownershipperiod": "P3Y",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1916442,
    "incometaxreconciliationpermanentdifferences": 142523,
    "incometaxreconciliationforeignincometaxratedifferential": -239465,
    "incometaxreconciliationeffectofforeignexchangerates": 347510,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 38252,
    "incometaxreconciliationotheradjustments": 322689,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1381437,
    "manufacturingandclinicalstudymanagementrelatedloanterm": "P1Y",
    "manufacturingandclinicalstudymanagementrelatedcost": 1419520,
    "clinicaldevelopmentresearchdeposits": 41938,
    "periodicleaserentterm": "P1Y",
    "periodicleaserentpayment": 4357,
    "leaseandrentalexpense": 40130,
    "dividendspreferredstockstock": 8616,
    "noncashissuecosts": 182257,
    "deferredcostsinaccountspayable": 59944,
    "warrantsissuedasdeferredcosts": 93701,
    "conversionofseriesbpreferredstocksharestocommonstock": 174407,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 152347,
    "descriptionofforeigncurrencyexposure": "Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If foreign exchange rates were to fluctuate within +/-10% of the closing rate at year-end, the maximum exposure is $17,853.",
    "foreignexchangeriskmaximumexposure": 17853,
    "descriptionofinterestrateriskexposure": "The Company’s cash balance currently earns interest at standard bank rates. If interest rates were to fluctuate within +/-10% of the closing rate at year end the impact of the Company’s interest-bearing accounts will be not be significant due to the current low market interest rates.",
    "liquidityriskmaximumexposure": 2674923,
    "concentrationriskcreditriskfinancialinstrumentmaximumexposure": 9401,
    "concentrationriskcreditriskuninsuredamountofcash": 2232270,
    "accountspayabletradecurrentandnoncurrent": 167499,
    "cash": 20981,
    "interestreceivableandotherassets": 12808,
    "cashfdicinsuredamount": 160132,
    "cashuninsuredamount": 2232270,
    "paymentsofstockissuancecosts": 84944,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexerciseperiod": "P90D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2020-11-19"
  },
  {
    "date": "2019-06-29",
    "symbol": "KTRA",
    "period": "FY",
    "entityregistrantname": "DelMar Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1498382,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--06-30",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-06-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-37823",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "cashandcashequivalentsatcarryingvalue": 3718758,
    "prepaidexpensecurrent": 280248,
    "taxesandotherreceivablescurrent": 26187,
    "assetscurrent": 4025193,
    "finitelivedintangibleassetsnet": 12062,
    "assets": 4037255,
    "accountspayableandaccruedliabilitiescurrent": 1744517,
    "duetorelatedpartiescurrent": 325208,
    "liabilitiescurrent": 2069725,
    "liabilities": 2069725,
    "preferredstockvalue": 4699304,
    "commonstockvalue": 3839,
    "additionalpaidincapitalcommonstock": 50954741,
    "warrantsandrightsoutstanding": 6588283,
    "retainedearningsaccumulateddeficit": -60578345,
    "accumulatedothercomprehensiveincomelossnetoftax": 21178,
    "stockholdersequity": 21178,
    "liabilitiesandstockholdersequity": 4037255,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "preferredstocksharesissued": 673613,
    "preferredstocksharesoutstanding": 673613,
    "preferredstockspecialvotingsharesissued": 1,
    "commonstocksharesauthorized": 95000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesissued": 780000,
    "researchanddevelopmentexpense": -3662056,
    "generalandadministrativeexpense": -4736440,
    "operatingexpenses": -8398496,
    "gainlossonderivativeinstrumentsnetpretax": -433503,
    "paymentsofderivativeissuancecosts": 126186,
    "foreigncurrencytransactiongainlossbeforetax": 17746,
    "otheroperatingincomeexpensenet": -60704,
    "nonoperatingincomeexpense": -350275,
    "netincomeloss": 8048221,
    "preferredstockdividendsandotheradjustments": -80431,
    "netincomelossavailabletocommonstockholdersbasic": 8128652,
    "earningspersharebasic": 3.16,
    "weightedaveragenumberofsharesoutstandingbasic": 2574692,
    "sharesoutstanding": 3839358,
    "issuanceofsharesandwarrantsnetofissuecost": 2332102,
    "issuanceofsharesandwarrantsnetofissuecostshare": 1170000,
    "exerciseandexchangeofwarrants": 2930565,
    "exerciseandexchangeofwarrantsinshares": 296667,
    "conversionofseriesbpreferredstocktocommonstock": -1447576,
    "conversionoffseriesbpreferredstocktocommonstockshares": 51876,
    "reclassificationofderivativeliabilitytoequity": 492884,
    "stockissuedduringperiodvalueissuedforservices": 13774,
    "stockissuedduringperiodsharesissuedforservices": 165485,
    "adjustmentofwarrantsgrantedforservices": 23715,
    "stockissuedduringperiodvaluereversestocksplits": 2,
    "stockissuedduringperiodsharesreversestocksplits": 2433,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 495925,
    "restrictedstockexpense": 526141,
    "seriespreferredstockdividends": -8356,
    "seriesbpreferredstockdividend": -80431,
    "seriesbpreferredstockdividendshares": 18271,
    "profitloss": -8048221,
    "noncashderivativeissuecosts": 13495,
    "amortizationofintangibleassets": 16349,
    "unrealizedgainlossonderivatives": 433503,
    "issuanceofstockforservices": 13777,
    "issuanceofstockandwarrantsforservicesorclaims": 23715,
    "sharebasedcompensation": 426029,
    "increasedecreaseinprepaidexpense": -754682,
    "increasedecreaseintaxesandotherreceivables": -13332,
    "increasedecreaseinaccountspayableandaccruedliabilities": 202000,
    "increasedecreaseinduetorelatedparties": 164779,
    "netcashprovidedbyusedinoperatingactivities": -6327425,
    "proceedsfromissuanceofsharesandwarrants": 3362379,
    "proceedsfromwarrantexercises": 720165,
    "paymentsofdividendspreferredstockandpreferencestock": 8356,
    "netcashprovidedbyusedinfinancingactivities": 4074188,
    "cashandcashequivalentsperiodincreasedecrease": -2253237,
    "derivativeliabilities": 29594,
    "paymentsforsoftware": 79910,
    "adjustmentforamortization": 16349,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 168427,
    "derivativegainlossonderivativenet": 432386,
    "fairvalueadjustmentofwarrants": 925270,
    "reclassificationofderivativeliabilitytoequityuponamendmentofdividendwarrants": -433503,
    "reclassificationtoequityuponexerciseofwarrants": 492884,
    "investorwarrants": 2180,
    "issuanceofwarrantsbalance": 2180,
    "issuanceofwarrantslongtermportion": 2180,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 30,
    "classofwarrantorrightissued": 2180,
    "warrantsexpirationdate": "2020-07-15",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 30000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionscancelledinperiod": -120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.825,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0271,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P3Y2M27D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 4500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 22.31,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 28.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P3Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3000,
    "allocatedsharebasedcompensationexpense": 351362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 138160,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 44241,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 2100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsunvestedweightedaverageexerciseprice": 14.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsgrantedweightedaverageexerciseprice": 11.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsvestedweightedaverageexerciseprice": 27.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsforfeitedweightedaverageexerciseprice": 21.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 7.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 15.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 11.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 1543775,
    "numberofwarrantsexerciseandexchangeofinvestorwarrants": -495000,
    "issuanceofinvestorwarrantssharesone": 760500,
    "issuanceofagentwarrantssharesone": 46800,
    "numberofwarrantsexerciseandexchangeofinvestorwarrantsvalue": -2210697,
    "issuanceofinvestorwarrantssharesonevalue": 492884,
    "issuanceofagentwarrantssharesonevalue": 52899,
    "stockissuedduringperiodwarrantsissuedforservices": 23715,
    "classofwarrantorrightoutstanding": 2180,
    "numberofwarrantsissuedtoinvestor": 760500,
    "exerciseofwarrantsissuedtoinvestorshares": 46800,
    "numberofwarrantsexerciseofinvestorwarrantsforcash": -197500,
    "numberofwarrantscashlessexchangeofinvestorwarrants": -297500,
    "warrantsissuedforservicesshare": 14000,
    "expiryofwarrants": -210832,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2020-07-15",
    "commonstocksharesoutstanding": 7813,
    "convertiblepreferredstocksharesissueduponconversion": 207500,
    "conversionofseriesbpreferredstocktocommonstockshares": 168427,
    "fullydilutedsharesofcommonstockpercentage": 0.08,
    "legacyplandescription": "Under the Legacy Plan and/or are subject to outstanding stock options granted under the Legacy Plan, and a total of 122,698 shares of common stock have been issued under the 2017 Plan and/or are subject to outstanding stock options granted under the 2017 Plan leaving a potential 491,817 shares of common stock available for issuance under the 2017 Plan if all such options under the Legacy Plan were exercised and no new grants are made under the Legacy Plan.",
    "employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense": 526141,
    "expenserelatedtotheperformancestockunits": 322877,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 164329,
    "unrecognizedcompensationexpenseterm": "P2Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P8Y9M11D",
    "warrantsdescription": "i) As part of the financing completed by the Company on September 22, 2017, the Company issued the 2018 Investor Warrants and the 2018 Agent Warrants. The 2018 Investor Warrants are exercisable at $12.50 until September 22, 2022 and the 2018 Agent Warrants are exercisable at $12.50 until September 20, 2022.",
    "deferredtaxassetsoperatinglosscarryforwards": 10823529,
    "deferredtaxassetscapitallosscarryforwards": 17925,
    "deferredtaxassetsinprocessresearchanddevelopment": 534398,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 484135,
    "deferredtaxassetsliabilitiesnet": 11859987,
    "deferredtaxliabilitiesscientificresearchanddevelopment": 81386,
    "deferredtaxassetsgross": 11778601,
    "deferredtaxassetsvaluationallowance": 11778601,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1690126,
    "incometaxreconciliationpermanentdifferences": -527532,
    "incometaxreconciliationforeignincometaxratedifferential": -429531,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": -39807,
    "incometaxreconciliationotheradjustments": 106320,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2580676,
    "investmenttaxcredit": 2000000,
    "taxcreditcarryforwarddescription": "Expire between 2019 and 2029.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 43200000,
    "operatinglosscarryforwardslimitationsonuse": "Expiring in 2029.",
    "manufacturingandclinicalstudymanagementrelatedcost": 659343,
    "clinicaldevelopmentresearchdeposits": 142568,
    "periodicleaserentpayment": 3725,
    "leaseandrentalexpense": 52926,
    "dividendspreferredstockstock": 80431,
    "noncashissuecosts": 52899,
    "issuecostsinaccountspayable": 64432,
    "reclassificationofderivativeliabilitytoequityuponexerciseofwarrants": 492884,
    "conversionofseriesbpreferredstocksharestocommonstock": 1447576,
    "accountspayabletradecurrentandnoncurrent": 201279,
    "cash": 24248,
    "interestreceivableandotherassets": 26099,
    "cashfdicinsuredamount": 75158,
    "cashuninsuredamount": 3643600,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 178327,
    "descriptionofforeigncurrencyexposure": "Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If foreign exchange rates were to fluctuate within +/-10% of the closing rate at year-end, the maximum exposure is $13,865.",
    "descriptionofinterestrateriskexposure": "The Company's cash balance currently earns interest at standard bank rates. If interest rates were to fluctuate within +/-10% of the closing rate at year end the impact of the Company's interest-bearing accounts will be not be significant due to the current low market interest rates.",
    "liquidityriskmaximumexposure": 2069725,
    "concentrationriskcreditriskfinancialinstrumentmaximumexposure": 26187,
    "stockissuedduringperiodsharesofcommonstockforservices": 25000,
    "conversionofstocksharesconverted1": 6250,
    "commonstockcapitalsharesreservedforfutureissuance": 491817,
    "increasesharesofcommonstockavailableforissuance": 1500000,
    "totalnumberofcommonstockavailableshares": 2280000
  }
]